Department of Neonatology, Children's Hospital of Chongqing Medical University/Ministry of Education Key Laboratory of Child Development and Disorders/National Clinical Research Center for Child Health and Disorders/China International Science and Technology Cooperation Base of Child Development and Critical Disorders/Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
Abstract Objective To evaluate the efficacy of sepsis risk calculator (SRC) in guiding antibiotic use in neonates with suspected early-onset sepsis (EOS). Methods A total of 284 neonates with a gestational age of ≥ 35 weeks were enrolled as the control group, who were hospitalized in the Children's Hospital of Chongqing Medical University from March to July, 2019 and were suspected of EOS. Their clinical data were retrospectively collected and the use of antibiotics was analyzed based on SRC. A total of 170 neonates with a gestational age of ≥ 35 weeks were enrolled as the study group, who were admitted to the hospital from July to November, 2020 and were suspected of EOS. SRC was used prospectively for risk scoring to assist the decision making of clinical antibiotic management. The two groups were compared in terms of the rate of use of antibiotics, blood culture test rate, clinical outcome, and adherence to the use of SRC. Results Compared with the control group, the study group had a significantly higher SRC score at birth and on admission (P < 0.05). The rate of use of antibiotics in the study group was significantly lower than that in the control group[84.7% (144/170) vs 91.5% (260/284), 6.8% decrease; P < 0.05]. The blood culture test rate in the study group was also significantly lower than that in the control group (85.3% vs 91.9%, P < 0.05). There was no significant difference between the two groups in the incidence rate of adverse outcomes and the final diagnosis of EOS (P > 0.05). Conclusions The use of SRC reduces the rate of empirical use of antibiotics in neonates with suspected EOS and does not increase the risk of adverse outcomes, and therefore, it holds promise for clinical application.
Kuzniewicz MW, Walsh EM, Li S, et al. Development and implementation of an early-onset sepsis calculator to guide antibiotic management in late preterm and term neonates[J]. Jt Comm J Qual Patient Saf, 2016, 42(5):232-239. DOI:10.1016/s1553-7250(16)42030-1. PMID:27066927.
Hviid A, Svanström H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood[J]. Gut, 2011, 60(1):49-54. DOI:10.1136/gut.2010.219683. PMID:20966024.
[4]
Troelsen FS, Jick S. Antibiotic use in childhood and adolescence and risk of inflammatory bowel disease:a case-control study in the UK clinical practice research datalink[J]. Inflamm Bowel Dis, 2020, 26(3):440-447. DOI:10.1093/ibd/izz137. PMID:31265060.
[5]
Saari A, Virta LJ, Sankilampi U, et al. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life[J]. Pediatrics, 2015, 135(4):617-626. DOI:10.1542/peds.2014-3407. PMID:25825533.
[6]
Puopolo KM, Draper D, Wi S, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors[J]. Pediatrics, 2011, 128(5):e1155-e1163. DOI:10.1542/peds.2010-3464. PMID:22025590.
[7]
Escobar GJ, Puopolo KM, Wi S, et al. Stratification of risk of early-onset sepsis in newborns ≥ 34 weeks' gestation[J]. Pediatrics, 2014, 133(1):30-36. DOI:10.1542/peds.2013-1689. PMID:24366992.
[8]
Morris R, Jones S, Banerjee S, et al. Comparison of the management recommendations of the Kaiser Permanente neonatal early-onset sepsis risk calculator (SRC) with NICE guideline CG149 in infants ≥ 34 weeks' gestation who developed early-onset sepsis[J]. Arch Dis Child Fetal Neonatal Ed, 2020, 105(6):581-586. DOI:10.1136/archdischild-2019-317165. PMID:32170032.
[9]
Goel N, Shrestha S, Smith R, et al. Screening for early onset neonatal sepsis:NICE guidance-based practice versus projected application of the Kaiser Permanente sepsis risk calculator in the UK population[J]. Arch Dis Child Fetal Neonatal Ed, 2020, 105(2):118-122. DOI:10.1136/archdischild-2018-316777. PMID:31296696.
[10]
Leonardi BM, Binder M, Griswold KJ, et al. Utilization of a neonatal early-onset sepsis calculator to guide initial newborn management[J]. Pediatr Qual Saf, 2019, 4(5):e214. DOI:10.1097/pq9.0000000000000214. PMID:31745517.
[11]
Dhudasia MB, Mukhopadhyay S, Puopolo KM. Implementation of the sepsis risk calculator at an academic birth hospital[J]. Hosp Pediatr, 2018, 8(5):243-250. DOI:10.1542/hpeds.2017-0180. PMID:29666161.
Kuzniewicz MW, Puopolo KM. Antibiotic stewardship for early-onset sepsis[J]. Semin Perinatol, 2020, 44(8):151325. DOI:10.1016/j.semperi.2020.151325. PMID:33221072.
[14]
Helmbrecht AR, Marfurt S, Chaaban H. Systematic review of the effectiveness of the neonatal early-onset sepsis calculator[J]. J Perinat Neonatal Nurs, 2019, 33(1):82-88. DOI:10.1097/JPN.0000000000000360. PMID:30676467.
[15]
Caffrey Osvald E, Prentice P. NICE clinical guideline:antibiotics for the prevention and treatment of early-onset neonatal infection[J]. Arch Dis Child Educ Pract Ed, 2014, 99(3):98-100. DOI:10.1136/archdischild-2013-304629. PMID:24334339.
[16]
Jefferies AL. Management of term infants at increased risk for early-onset bacterial sepsis[J]. Paediatr Child Health, 2017, 22(4):223-228. DOI:10.1093/pch/pxx023. PMID:29480905.
[17]
Arora V, Strunk D, Furqan SH, et al. Optimizing antibiotic use for early onset sepsis:a tertiary NICU experience[J]. J Neonatal Perinatal Med, 2019, 12(3):301-312. DOI:10.3233/NPM-180075. PMID:30932898.
[18]
Pettinger KJ, Mayers K, Mckechnie L, et al. Sensitivity of the Kaiser Permanente early-onset sepsis calculator:a systematic review and meta-analysis[J]. EClinicalMedicine, 2020, 19:100227. DOI:10.1016/j.eclinm.2019.11.020. PMID:32140666.
[19]
Kuzniewicz MW, Puopolo KM, Fischer A, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis[J]. JAMA Pediatr, 2017, 171(4):365-371. DOI:10.1001/jamapediatrics.2016.4678. PMID:28241253.
[20]
Benaim EH, Upadhyay K, Talati AJ. Comparison of institutional guidelines with established early onset sepsis risk calculator in reducing antibiotic use in an inner-city NICU in US[J]. J Glob Antimicrob Resist, 2020, 21:124-129. DOI:10.1016/j.jgar.2020.03.015. PMID:32234556.
[21]
Tiskumara R, Fakharee SH, Liu CQ, et al. Neonatal infections in Asia[J]. Arch Dis Child Fetal Neonatal Ed, 2009, 94(2):F144-F148. DOI:10.1136/adc.2008.139865. PMID:18805822.
[22]
Cantoni L, Ronfani L, Da Riol R, et al. Physical examination instead of laboratory tests for most infants born to mothers colonized with group B Streptococcus:support for the Centers for Disease Control and Prevention's 2010 recommendations[J]. J Pediatr, 2013, 163(2):568-573. DOI:10.1016/j.jpeds.2013.01.034. PMID:23477995.
[23]
Bhandari V. Effective biomarkers for diagnosis of neonatal sepsis[J]. J Pediatric Infect Dis Soc, 2014, 3(3):234-245. DOI:10.1093/jpids/piu063. PMID:26625387.
[24]
Coggins SA, Wynn JL, Hill ML, et al. Use of a computerized C-reactive protein (CRP) based sepsis evaluation in very low birth weight (VLBW) infants:a five-year experience[J]. PLoS One, 2013, 8(11):e78602. DOI:10.1371/journal.pone.0078602. PMID:24244325.
